Post by account_disabled on Jan 14, 2024 8:08:12 GMT 1
The organ-on-chip opens channels for academic research, and scientists can use the model for the development of personalized medicinal drugs. model for the drug discovery and determine the potency of drug. Organ-on-chip is also used to determine the safety of drugs for patient use and shorten the timeline between clinical trials and market supply. ▪ Organ-on-a-Chip Is Used to Study Lung Inflammation Organ-on-a-chip technology also helps to study lung inflammation, specifically in the alveolar region. The alveoli are elastic sacs inside the lungs where the exchange of oxygen and carbon dioxide takes place. Patients with severe COVID-19 infection face acute respiratory distress syndrome, which damages the alveolar sac.
Benefits of Organ on a Chip Technology Organ on chip serves as a B2C Cell Phone Number List tissue-specific dynamic cell culture system that allows real-time analysis of drug effects on the human body using this model. Other significances of using organ-on-a-chip technology are as follows: ▪ Organ-on-chip technology contains human tissues that mimic the human relevance model to study drug development. ▪ It creates a microenvironment for real-time data analysis useful for drug discovery. ▪ Organ-on-chip technology is comparatively less expensive than in-vivo culture for drug development. ▪ Reduces dependency on human volunteers for drug development clinical trials. Organ on a Chip Market: Future Perspectives and Market Growth Organ on a chip is a portable and easy-to-use cell culture model.
Pharmaceutical players are adopting it at the global level for drug discovery. of the drug potency and efficacy. Several pharmaceutical players are showing active participation in the use of organ-on-a-chip technology for clinical trials. Driven by these factors, the global organ-on-a-chip market has been anticipated to grow at a CAGR of 21%, according to Roots Analysis. Some of the recent development that has taken place in the organ-on-a-chip market includes: ▪ In June 2023, MatTek Life Sciences announced its strategic partnership with AIM Biotech. The partnership allows MatTek to sell their products using AIM Biotech Portfolio. ▪ In June 2023, Emulate Launched Emulate Chip-A1™ to spread its application in the cosmetic market and cancer study. Concluding Remarks Organ-on-a-chip is a verified preclinical model that provides better insight into human physiology and disease pathways. Pharmaceutical players are leveraging this model to overcome the issues they face during traditional preclinical models.
Benefits of Organ on a Chip Technology Organ on chip serves as a B2C Cell Phone Number List tissue-specific dynamic cell culture system that allows real-time analysis of drug effects on the human body using this model. Other significances of using organ-on-a-chip technology are as follows: ▪ Organ-on-chip technology contains human tissues that mimic the human relevance model to study drug development. ▪ It creates a microenvironment for real-time data analysis useful for drug discovery. ▪ Organ-on-chip technology is comparatively less expensive than in-vivo culture for drug development. ▪ Reduces dependency on human volunteers for drug development clinical trials. Organ on a Chip Market: Future Perspectives and Market Growth Organ on a chip is a portable and easy-to-use cell culture model.
Pharmaceutical players are adopting it at the global level for drug discovery. of the drug potency and efficacy. Several pharmaceutical players are showing active participation in the use of organ-on-a-chip technology for clinical trials. Driven by these factors, the global organ-on-a-chip market has been anticipated to grow at a CAGR of 21%, according to Roots Analysis. Some of the recent development that has taken place in the organ-on-a-chip market includes: ▪ In June 2023, MatTek Life Sciences announced its strategic partnership with AIM Biotech. The partnership allows MatTek to sell their products using AIM Biotech Portfolio. ▪ In June 2023, Emulate Launched Emulate Chip-A1™ to spread its application in the cosmetic market and cancer study. Concluding Remarks Organ-on-a-chip is a verified preclinical model that provides better insight into human physiology and disease pathways. Pharmaceutical players are leveraging this model to overcome the issues they face during traditional preclinical models.